Mark VanRaden

2.4k total citations · 1 hit paper
20 papers, 1.8k citations indexed

About

Mark VanRaden is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Mark VanRaden has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Mark VanRaden's work include HIV Research and Treatment (4 papers), HIV/AIDS Research and Interventions (4 papers) and Hepatitis B Virus Studies (3 papers). Mark VanRaden is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS Research and Interventions (4 papers) and Hepatitis B Virus Studies (3 papers). Mark VanRaden collaborates with scholars based in United States, Vietnam and Spain. Mark VanRaden's co-authors include Richard A. Kaslow, Lawrence Kingsley, John Phair, Roger Detels, Harvey J. Alter, Cathy Conry‐Cantilena, Jacqueline C. Melpolder, A. Obaid Shakil, J W Shih and Joan Gibble and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Statistical Association.

In The Last Decade

Mark VanRaden

20 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection

1996 510 citations Cathy Conry‐Cantilena, Mark VanRaden et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark VanRaden United States	13	900	825	490	355	296	20	1.8k
Noah Jamie Robinson United Kingdom	22	529 0.6×	1.3k 1.6×	182 0.4×	87 0.2×	261 0.9×	41	2.3k
Katharine J Looker United Kingdom	20	660 0.7×	2.3k 2.8×	180 0.4×	161 0.5×	395 1.3×	39	3.2k
Ana Rita Coimbra Motta-Castro Brazil	22	512 0.6×	979 1.2×	607 1.2×	67 0.2×	62 0.2×	104	1.5k
Niel T. Constantine United States	27	1.0k 1.1×	1.1k 1.3×	536 1.1×	110 0.3×	583 2.0×	87	2.5k
Margaret Fearon Canada	25	849 0.9×	898 1.1×	242 0.5×	79 0.2×	53 0.2×	54	1.7k
Anders Tegnell Sweden	23	614 0.7×	682 0.8×	108 0.2×	124 0.3×	110 0.4×	71	2.0k
Rivaldo Venâncio da Cunha Brazil	27	1.2k 1.3×	637 0.8×	80 0.2×	181 0.5×	86 0.3×	119	2.3k
Mercedes Weissenbacher Argentina	25	1.1k 1.2×	651 0.8×	135 0.3×	44 0.1×	162 0.5×	109	1.7k
Marta Heloísa Lopes Brazil	20	298 0.3×	1.2k 1.4×	259 0.5×	194 0.5×	90 0.3×	75	1.6k
Virat Sirisanthana Thailand	29	1.5k 1.7×	768 0.9×	102 0.2×	199 0.6×	656 2.2×	78	2.2k

Countries citing papers authored by Mark VanRaden

Since Specialization

Citations

This map shows the geographic impact of Mark VanRaden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark VanRaden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark VanRaden more than expected).

Fields of papers citing papers by Mark VanRaden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark VanRaden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark VanRaden. The network helps show where Mark VanRaden may publish in the future.

Co-authorship network of co-authors of Mark VanRaden

This figure shows the co-authorship network connecting the top 25 collaborators of Mark VanRaden. A scholar is included among the top collaborators of Mark VanRaden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark VanRaden. Mark VanRaden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Griffith, Linda M., Mark VanRaden, A. John Barrett, et al.. (2018). Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993–2010): factors that predict intensity and time to transfusion independence. Transfusion. 59(1). 303–315. 15 indexed citations

Ames, Nancy J., John H. Powers, Li Yang, et al.. (2017). A systematic approach for studying the signs and symptoms of fever in adult patients: the fever assessment tool (FAST). Health and Quality of Life Outcomes. 15(1). 84–84. 7 indexed citations

Stark, Gregory V., Katherine Taylor, Mark VanRaden, et al.. (2016). Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge. Vaccine. 34(51). 6518–6528. 10 indexed citations

Stark, Gregory V., Mark VanRaden, Jarad Schiffer, et al.. (2016). Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing. Vaccine. 34(51). 6512–6517. 11 indexed citations

Rose, Stacey, Saraschandra Vallabhajosyula, Daniel P. Fedorko, et al.. (2014). The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections. Journal of Infection. 69(3). 278–283. 55 indexed citations

Ames, Nancy J., John H. Powers, Nancy Kline Leidy, et al.. (2013). Beyond Intuition: Patient Fever Symptom Experience. Journal of Pain and Symptom Management. 46(6). 807–816. 13 indexed citations

Jewett, Mollie W., Aaron Bestor, Kit Tilly, et al.. (2007). The critical role of the linear plasmid lp36 in the infectious cycle ofBorrelia burgdorferi. Molecular Microbiology. 64(5). 1358–1374. 101 indexed citations

Tilly, Kit, Jonathan G. Krum, Aaron Bestor, et al.. (2006). Borrelia burgdorferi OspC Protein Required Exclusively in a Crucial Early Stage of Mammalian Infection. Infection and Immunity. 74(6). 3554–3564. 259 indexed citations

Chen-Mok, Mario, Mark VanRaden, Elizabeth S. Higgs, & Rosalie Dominik. (2006). Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network. Clinical Trials. 3(5). 469–477. 1 indexed citations

10.

Blackwelder, William C., Mark VanRaden, & Maria Deloria Knoll. (1997). Estimation of pertussis vaccine efficacy in the presence of covariates in three randomized trials.. PubMed. 89. 161–6. 1 indexed citations

11.

Conry‐Cantilena, Cathy, Mark VanRaden, Joan Gibble, et al.. (1996). Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection. New England Journal of Medicine. 334(26). 1691–1696. 510 indexed citations breakdown →

12.

Conry‐Cantilena, Cathy, et al.. (1995). Porphyria cutanea tarda in hepatitis C virus-infected blood donors. Journal of the American Academy of Dermatology. 32(3). 512–514. 5 indexed citations

13.

Hoover, Donald R., Álvaro Muñoz, Vincent J. Carey, et al.. (1993). Using Events From Dropouts in Nonparametric Survival Function Estimation With Application to Incubation of AIDS. Journal of the American Statistical Association. 88(421). 37–43. 6 indexed citations

14.

Kingsley, Lawrence, Susan Zhou, Helena Bacellar, et al.. (1991). Temporal Trends in Human Immunodeficiency Virus type 1 Seroconversion 1984–1989. American Journal of Epidemiology. 134(4). 331–339. 67 indexed citations

15.

Ostrow, David G., et al.. (1990). Recreational drug use and sexual behavior change in a cohort of homosexual men. AIDS. 4(8). 759–766. 92 indexed citations

16.

Solomon, Rachel, Mark VanRaden, Richard A. Kaslow, et al.. (1990). Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection.. American Journal of Public Health. 80(12). 1475–1478. 36 indexed citations

17.

Kaslow, Richard A., Mark VanRaden, H. Friedman, et al.. (1990). A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. The Lancet. 335(8695). 927–930. 166 indexed citations

18.

Alter, Harvey J., Jay S. Epstein, Mark VanRaden, et al.. (1990). Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening. New England Journal of Medicine. 323(19). 1312–1317. 72 indexed citations

19.

Ostrow, David G., Andrew A. Monjan, J. Joseph, et al.. (1989). HIV-related symptoms and psychological functioning in a cohort of homosexual men. American Journal of Psychiatry. 146(6). 737–742. 172 indexed citations

20.

Kingsley, Lawrence, Richard A. Kaslow, Katherine M. Detre, et al.. (1987). RISK FACTORS FOR SEROCONVERSION TO HUMAN IMMUNODEFICIENCY VIRUS AMONG MALE HOMOSEXUALS. The Lancet. 329(8529). 345–349. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact